FACE IPF
HEAD ON
and modify disease progression by slowing lung function decline
![thumbnail-image](/mea/lb/sites/default/files/2023-08/media%402x.png)
Prof. Wim Wuyts, Prof. Vincent Cottin, Dr. Anna-Maria Hoffmann-Vold and Prof. Luca Richeldi discussing Risk of Acute Exacerbations in OFEV
24/05/2022 | Author: Boehringer Ingelheim
Prof. Wim Wuyts, Prof. Vincent Cottin, Dr. Anna-Maria Hoffmann-Vold and Prof. Luca Richeldi discussing Risk of Acute Exacerbations in OFEV
Document ID: PC-LB-100402